Companies: 10,795·Total market cap: $144.5T
CVS Health Corporation

CVS Health Corporation

CVSNYSEHealthcare● Active
$96.55
+$0.62(+0.65%)
Market Cap$123.2B
P/E Ratio
52W High$98.43
52W Low$58.5
Overview

CVS Health Corporation (CVS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000064803 · CVS · NYSE · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
4
Latest Form
2026-06-01
Most Recent
1996
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0000064803 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-10
Fiscal Year End
Feb 10, 2026
Accession No.
0000064803-26-000010
Primary Document
cvs-20251231.htm
Source: data.sec.gov · CIK 0000064803 · Accession 0000064803-26-000010

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-06
8-KCurrent Report
8-K
2026-05-18Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
S-8Employee Stock Plan Registration
S-8
2026-05-22
View
S-3ASRS-3ASR
S-3ASR
2026-05-22
View
8-KCurrent Report
8-K
2026-05-18
View
13F-HR13F-HR
13F-HR
2026-05-07
View
10-QQuarterly Report
10-Q
2026-05-06
View
8-KCurrent Report
8-K
2026-05-06
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
ARSARS
ANNUAL REPORT TO SECURITY HOLDERS
2026-04-03
View
DEFA14AProxy Statement (Additional)
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
2026-04-03
View
DEF 14AProxy Statement
DEFINITIVE PROXY STATEMENT
2026-04-03
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-03-19
View
8-KCurrent Report
8-K
2026-03-19
View
13F-HR13F-HR
13F-HR
2026-02-13
View
10-KAnnual Report
10-K
2026-02-10
View
Showing 1–15 of 456 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000064803  |  Exchange: NYSE · Healthcare

CVS Health Corporation (NYSE: CVS) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1996. As a Healthcare sector company with CIK 0000064803, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is CVS Health Corporation's most comprehensive regulatory disclosure. The most recent CVS Health Corporation 10-K was filed on 2026-02-10 for fiscal year ending 2026. Historical CVS 10-K annual reports are available from 2017 through 2026.

Investors researching CVS Health Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

CVS SEC Filings · 8 questions

CVS Health Corporation (CVS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. CVS Health Corporation's CIK is 0000064803.

CVS SEC filingsCVS Health Corporation SEC documentsfind CVS 10-K